Veracyte
VCYT
#4729
Rank
A$3.04 B
Marketcap
A$37.75
Share price
0.36%
Change (1 day)
-39.02%
Change (1 year)

Earnings for Veracyte (VCYT)

Earnings in 2026 (TTM): A$0.17 Billion

According to Veracyte's latest financial reports the company's current earnings are A$0.56 Billion. In 2025 the company made an earning of A$0.10 Billion, an increase over its 2024 earnings that were of A$36.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veracyte from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B66.81%
2025 A$0.10 B184.15%
2024 A$36.05 M-131.34%
2023 -A$0.12 Billion111.42%
2022 -A$54.44 Million-55.5%
2021 -A$0.13 Billion134.74%
2020 -A$52.11 Million190.89%
2019 -A$17.92 Million-43.33%
2018 -A$31.61 Million-23.78%
2017 -A$41.47 Million-3.51%
2016 -A$42.97 Million-14.17%
2015 -A$50.07 Million15.17%
2014 -A$43.47 Million14.15%
2013 -A$38.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exact Sciences
EXAS
-A$0.28 Billion-257.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.58 Billion-432.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$52.54 Million-130.14%๐Ÿ‡บ๐Ÿ‡ธ USA